These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 35577910)
1. Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice. Cao G; Miao H; Wang YN; Chen DQ; Wu XQ; Chen L; Guo Y; Zou L; Vaziri ND; Li P; Zhao YY Acta Pharmacol Sin; 2022 Nov; 43(11):2929-2945. PubMed ID: 35577910 [TBL] [Abstract][Full Text] [Related]
2. Microparticles derived from human erythropoietin mRNA-transfected mesenchymal stem cells inhibit epithelial-to-mesenchymal transition and ameliorate renal interstitial fibrosis. Lee M; Kim SH; Jhee JH; Kim TY; Choi HY; Kim HJ; Park HC Stem Cell Res Ther; 2020 Sep; 11(1):422. PubMed ID: 32993806 [TBL] [Abstract][Full Text] [Related]
3. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition. Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376 [TBL] [Abstract][Full Text] [Related]
4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related]
5. Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation. Wang M; Hu HH; Chen YY; Chen L; Wu XQ; Zhao YY Phytomedicine; 2020 Dec; 79():153323. PubMed ID: 32920287 [TBL] [Abstract][Full Text] [Related]
6. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590 [TBL] [Abstract][Full Text] [Related]
7. microRNA-29b prevents renal fibrosis by attenuating renal tubular epithelial cell-mesenchymal transition through targeting the PI3K/AKT pathway. Hu S; Hu H; Wang R; He H; Shui H Int Urol Nephrol; 2021 Sep; 53(9):1941-1950. PubMed ID: 33742315 [TBL] [Abstract][Full Text] [Related]
8. Intermedin attenuates renal fibrosis by induction of heme oxygenase-1 in rats with unilateral ureteral obstruction. Qiao X; Wang L; Wang Y; Su X; Qiao Y; Fan Y; Peng Z BMC Nephrol; 2017 Jul; 18(1):232. PubMed ID: 28697727 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy. Wang YN; Miao H; Yu XY; Guo Y; Su W; Liu F; Cao G; Zhao YY Free Radic Biol Med; 2023 Oct; 207():89-106. PubMed ID: 37451370 [TBL] [Abstract][Full Text] [Related]
10. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2. Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450 [TBL] [Abstract][Full Text] [Related]
11. Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation. Miao H; Cao G; Wu XQ; Chen YY; Chen DQ; Chen L; Vaziri ND; Feng YL; Su W; Gao Y; Zhuang S; Yu XY; Zhang L; Guo Y; Zhao YY Br J Pharmacol; 2020 Aug; 177(15):3415-3435. PubMed ID: 32219844 [TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Zhao S; Li W; Yu W; Rao T; Li H; Ruan Y; Yuan R; Li C; Ning J; Li S; Chen W; Cheng F; Zhou X Theranostics; 2021; 11(18):8660-8673. PubMed ID: 34522205 [No Abstract] [Full Text] [Related]
15. A direct thrombin inhibitor, dabigatran etexilate protects from renal fibrosis by inhibiting protease activated receptor-1. Saifi MA; Annaldas S; Godugu C Eur J Pharmacol; 2021 Feb; 893():173838. PubMed ID: 33359646 [TBL] [Abstract][Full Text] [Related]
16. Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy. Li A; Zhang X; Shu M; Wu M; Wang J; Zhang J; Wang R; Li P; Wang Y Phytomedicine; 2017 Jul; 30():28-41. PubMed ID: 28545667 [TBL] [Abstract][Full Text] [Related]
18. [Expression of kinesin KIF3A in the kidney of mice with unilateral ureteral obstruction]. Gu W; Pan W; Zhu Q; Xiao X; Zhao Y; Liu Y; Liu J; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb; 40(2):219-224. PubMed ID: 32376524 [TBL] [Abstract][Full Text] [Related]
19. The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Nakagawa N; Yuhki K; Kawabe J; Fujino T; Takahata O; Kabara M; Abe K; Kojima F; Kashiwagi H; Hasebe N; Kikuchi K; Sugimoto Y; Narumiya S; Ushikubi F Kidney Int; 2012 Jul; 82(2):158-71. PubMed ID: 22513820 [TBL] [Abstract][Full Text] [Related]
20. 1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway. Miao H; Wu XQ; Wang YN; Chen DQ; Chen L; Vaziri ND; Zhuang S; Guo Y; Su W; Ma SX; Zhang HQ; Shang YQ; Yu XY; Zhao YL; Mao JR; Gao M; Zhang JH; Zhao J; Zhang Y; Zhang L; Zhao YY; Cao G Br J Pharmacol; 2022 Jan; 179(1):103-124. PubMed ID: 34625952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]